{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:46:01Z","timestamp":1785523561281,"version":"3.56.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Fundamental Research Funds for the Central Universities, Peking Union Medical College","award":["3332025091"],"award-info":[{"award-number":["3332025091"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2025ZD0548700"],"award-info":[{"award-number":["2025ZD0548700"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370041"],"award-info":[{"award-number":["82370041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Peking Union Medical College Hospital Talent Cultivation Program","award":["UGG06079"],"award-info":[{"award-number":["UGG06079"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-026-09184-0","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:27:46Z","timestamp":1785194866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of Inborn Errors of Immunity in China: Discoveries and Treatment Paradigms"],"prefix":"10.1007","volume":"69","author":[{"given":"Yu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"7","key":"9184_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, Al-Herz W, Bousfiha A et al (2022) Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee[J]. J Clin Immunol 42(7):1473\u20131507. https:\/\/doi.org\/10.1007\/s10875-022-01289-3","journal-title":"J Clin Immunol"},{"key":"9184_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1098\/rspb.1939.0044","volume":"128","author":"O von Verschuer","year":"1939","unstructured":"von Verschuer O (1939) Twin research from the time of Francis Galton to the present-day[J]. Proc R Soc Lond B 128:62\u201381","journal-title":"Proc R Soc Lond B"},{"issue":"6","key":"9184_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"OC Bruton","year":"1952","unstructured":"Bruton OC (1952) Agammaglobulinemia[J] Pediatr 9(6):722\u2013728","journal-title":"Agammaglobulinemia[J] Pediatr"},{"issue":"8","key":"9184_CR4","first-page":"561","volume":"42","author":"X-Q Yang","year":"2004","unstructured":"Yang X-Q (2004) [History, status quo and expectation of primary immunodeficiency][J]. Zhonghua Er Ke Za Zhi 42(8):561\u2013563","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"9184_CR5","first-page":"7","volume":"6","author":"D Ying","year":"1999","unstructured":"Ying D, Wang X, Yang X (1999) Collaborative network and registration work for primary immunodeficiency diseases[J]. Chin J Pediat 6:7\u20138","journal-title":"Chin J Pediat"},{"issue":"1","key":"9184_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A et al (2020) Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee[J]. J Clin Immunol 40(1):24\u201364. https:\/\/doi.org\/10.1007\/s10875-019-00737-x","journal-title":"J Clin Immunol"},{"issue":"3","key":"9184_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41576-023-00656-z","volume":"25","author":"YT Akalu","year":"2024","unstructured":"Akalu YT, Bogunovic D (2024) Inborn errors of immunity: an expanding universe of disease and genetic architecture[J]. Nat Rev Genet 25(3):184\u2013195. https:\/\/doi.org\/10.1038\/s41576-023-00656-z","journal-title":"Nat Rev Genet"},{"issue":"1","key":"9184_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/cei.12496","volume":"178","author":"B Grimbacher","year":"2014","unstructured":"Grimbacher B (2014) The European Society for Immunodeficiencies (ESID) registry 2014[J]. Clin Exp Immunol 178(1):18\u201320. https:\/\/doi.org\/10.1111\/cei.12496","journal-title":"Clin Exp Immunol"},{"key":"9184_CR9","doi-asserted-by":"publisher","unstructured":"Kindle G, Alligon M, Albert MH et al (2025) Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994\u20132024 report on 30,628 patients[J]. J Hum Immun 1(3). https:\/\/doi.org\/10.70962\/jhi.20250007","DOI":"10.70962\/jhi.20250007"},{"issue":"5","key":"9184_CR10","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.jaip.2017.12.002","volume":"6","author":"Z Rubin","year":"2018","unstructured":"Rubin Z, Pappalardo A, Schwartz A et al (2018) Prevalence and Outcomes of Primary Immunodeficiency in Hospitalized Children in the United States[J]. J Allergy Clin Immunol Pract 6(5):1705. https:\/\/doi.org\/10.1016\/j.jaip.2017.12.002.10.e1","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"9184_CR11","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jaci.2024.01.011","volume":"153","author":"NL Rider","year":"2024","unstructured":"Rider NL, Truxton A, Ohrt T et al (2024) Validating inborn error of immunity prevalence and risk with nationally representative electronic health record data[J]. J Allergy Clin Immunol 153(6):1704\u20131710. https:\/\/doi.org\/10.1016\/j.jaci.2024.01.011","journal-title":"J Allergy Clin Immunol"},{"key":"9184_CR12","doi-asserted-by":"publisher","unstructured":"Kirkpatrick P, Riminton S (2007) Primary immunodeficiency diseases in Australia and New Zealand[J]. J Clin Immunol 27(5): 517\u2009\u2013\u200924. https:\/\/doi.org\/10.1007\/s10875-007-9105-z","DOI":"10.1007\/s10875-007-9105-z"},{"key":"9184_CR13","unstructured":"Jin Y, Wu J, Su X-Y et al The History and Present Situation of Inborn Errors of Immunity in China: A Single Center\u2019s Experience Over 47 Years (1974\u20132021) and Review of the Literature[J]. Available at SSRN 4237735"},{"key":"9184_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.20.25322586","author":"G Kindle","year":"2025","unstructured":"Kindle G, Alligon M, Albert MH et al (2025) Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994\u20132024 report on 30,628 patients[J]. medRxiv. https:\/\/doi.org\/10.1101\/2025.02.20.25322586","journal-title":"medRxiv"},{"issue":"1","key":"9184_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12887-019-1729-7","volume":"19","author":"J Wu","year":"2019","unstructured":"Wu J, Zhong W, Yin Y et al (2019) Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center[J]. BMC Pediatr 19(1):410. https:\/\/doi.org\/10.1186\/s12887-019-1729-7","journal-title":"BMC Pediatr"},{"issue":"5","key":"9184_CR16","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","volume":"148","author":"J Thalhammer","year":"2021","unstructured":"Thalhammer J, Kindle G, Nieters A et al (2021) Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations[J]. J Allergy Clin Immunol 148(5):1332\u20131341. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.015.e5","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9184_CR17","first-page":"27","volume":"79","author":"WHO","year":"2004","unstructured":"WHO (2004) BCG vaccine. WHO position paper[J]. Wkly Epidemiol Rec 79(4):27\u201338","journal-title":"Wkly Epidemiol Rec"},{"key":"9184_CR18","doi-asserted-by":"publisher","unstructured":"Li J, Lu J, Wang G et al (2022) Past, present and future of bacillus Calmette-Gu\u00e9rin vaccine use in China[J]. Vaccines (Basel) 10(7). https:\/\/doi.org\/10.3390\/vaccines10071157","DOI":"10.3390\/vaccines10071157"},{"issue":"40","key":"9184_CR19","doi-asserted-by":"publisher","first-page":"e44935","DOI":"10.1097\/md.0000000000044935","volume":"104","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang Y, Ning Y et al (2025) Current status of BCG and OPV vaccination in children with primary immunodeficiency in Chongqing, China[J]. Med (Baltim) 104(40):e44935. https:\/\/doi.org\/10.1097\/md.0000000000044935","journal-title":"Med (Baltim)"},{"issue":"1","key":"9184_CR20","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S (2023) WHO\u2019s global tuberculosis report 2022[J]. Lancet Microbe 4(1):e20","journal-title":"Lancet Microbe"},{"issue":"1","key":"9184_CR21","doi-asserted-by":"publisher","first-page":"2537482","DOI":"10.1080\/21645515.2025.2537482","volume":"21","author":"L Li","year":"2025","unstructured":"Li L, Xu J, Cai J et al (2025) Analysis of three cases of disseminated BCG infection in infants after BCG vaccination in Beijing, China[J]. Hum Vaccin Immunother 21(1):2537482. https:\/\/doi.org\/10.1080\/21645515.2025.2537482","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"9184_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s10875-022-01422-2","volume":"43","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Ying W, Wang W et al (2023) Clinical and Genetic Characteristics of BCG Disease in Chinese Children: a Retrospective Study[J]. J Clin Immunol 43(4):756\u2013768. https:\/\/doi.org\/10.1007\/s10875-022-01422-2","journal-title":"J Clin Immunol"},{"key":"9184_CR23","doi-asserted-by":"publisher","first-page":"1570382","DOI":"10.3389\/fcimb.2025.1570382","volume":"15","author":"H Chen","year":"2025","unstructured":"Chen H, Yang X, Huang Y et al (2025) Clinical characteristics and genetic features of 35 cases of adverse reactions to Bacillus Calmette-Gu\u00e9rin vaccine in children[J]. Front Cell Infect Microbiol 15:1570382. https:\/\/doi.org\/10.3389\/fcimb.2025.1570382","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"9184_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s10875-014-0061-0","volume":"34","author":"H Xu","year":"2014","unstructured":"Xu H, Tian W, Li SJ et al (2014) Clinical and molecular features of 38 children with chronic granulomatous disease in mainland china[J]. J Clin Immunol 34(6):633\u2013641. https:\/\/doi.org\/10.1007\/s10875-014-0061-0","journal-title":"J Clin Immunol"},{"issue":"4","key":"9184_CR25","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","volume":"133","author":"BE Marciano","year":"2014","unstructured":"Marciano BE, Huang CY, Joshi G et al (2014) BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies[J]. J Allergy Clin Immunol 133(4):1134\u20131141. https:\/\/doi.org\/10.1016\/j.jaci.2014.02.028","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9184_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jgg.2020.03.003","volume":"47","author":"G Liu","year":"2020","unstructured":"Liu G, Xiao H, Liu L et al (2020) Severe cases of BCGosis-susceptible primary immunodeficiency diseases identified by next-generation sequencing: Implications for adjustment of BCG vaccination timing in China[J]. J Genet Genomics 47(4):229\u2013232. https:\/\/doi.org\/10.1016\/j.jgg.2020.03.003","journal-title":"J Genet Genomics"},{"issue":"8","key":"9184_CR27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s10875-018-0568-x","volume":"38","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang W, Liu L et al (2018) Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase \u03b4 Syndrome[J]. J Clin Immunol 38(8):854\u2013863. https:\/\/doi.org\/10.1007\/s10875-018-0568-x","journal-title":"J Clin Immunol"},{"issue":"2","key":"9184_CR28","first-page":"141","volume":"16","author":"L Tianci","year":"2021","unstructured":"Tianci L, Ying W, Wenjie W et al (2021) The clinical and immune features of patients with CARD11 mutations located in atypic domain[J]. Chin J Evidence-Based Pediatr 16(2):141","journal-title":"Chin J Evidence-Based Pediatr"},{"issue":"5","key":"9184_CR29","doi-asserted-by":"publisher","first-page":"e1138","DOI":"10.1002\/cti2.1138","volume":"9","author":"J Sun","year":"2020","unstructured":"Sun J, Yang L, Lu Y et al (2020) Screening for primary immunodeficiency diseases by next-generation sequencing in early life[J]. Clin Transl Immunol 9(5):e1138. https:\/\/doi.org\/10.1002\/cti2.1138","journal-title":"Clin Transl Immunol"},{"issue":"7","key":"9184_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/nejm199902183400703","volume":"340","author":"RH Buckley","year":"1999","unstructured":"Buckley RH, Schiff SE, Schiff RI et al (1999) Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency[J]. N Engl J Med 340(7):508\u2013516. https:\/\/doi.org\/10.1056\/nejm199902183400703","journal-title":"N Engl J Med"},{"issue":"5","key":"9184_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1401177","volume":"371","author":"SY Pai","year":"2014","unstructured":"Pai SY, Logan BR, Griffith LM et al (2014) Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009[J]. N Engl J Med 371(5):434\u2013446. https:\/\/doi.org\/10.1056\/NEJMoa1401177","journal-title":"N Engl J Med"},{"issue":"10396","key":"9184_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0140-6736(23)00731-6","volume":"402","author":"MS Thakar","year":"2023","unstructured":"Thakar MS, Logan BR, Puck JM et al (2023) Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium[J]. Lancet 402(10396):129\u2013140. https:\/\/doi.org\/10.1016\/s0140-6736(23)00731-6","journal-title":"Lancet"},{"issue":"11","key":"9184_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s001090100271","volume":"79","author":"MD Hazenberg","year":"2001","unstructured":"Hazenberg MD, Verschuren MC, Hamann D et al (2001) T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation[J]. J Mol Med (Berl) 79(11):631\u2013640. https:\/\/doi.org\/10.1007\/s001090100271","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"9184_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1084\/jem.20060964","volume":"204","author":"MC van Zelm","year":"2007","unstructured":"van Zelm MC, Szczepanski T, van der Burg M et al (2007) Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion[J]. J Exp Med 204(3):645\u2013655. https:\/\/doi.org\/10.1084\/jem.20060964","journal-title":"J Exp Med"},{"key":"9184_CR35","doi-asserted-by":"publisher","first-page":"j3294","DOI":"10.1136\/bmj.j3294","volume":"358","author":"MG Seidel","year":"2017","unstructured":"Seidel MG (2017) Baby genome screening: paving the way to genetic discrimination?[J]. BMJ 358:j3294. https:\/\/doi.org\/10.1136\/bmj.j3294","journal-title":"BMJ"},{"issue":"22","key":"9184_CR36","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1001\/jama.2009.1806","volume":"302","author":"JM Routes","year":"2009","unstructured":"Routes JM, Grossman WJ, Verbsky J et al (2009) Statewide newborn screening for severe T-cell lymphopenia[J]. JAMA 302(22):2465\u20132470. https:\/\/doi.org\/10.1001\/jama.2009.1806","journal-title":"JAMA"},{"key":"9184_CR37","doi-asserted-by":"publisher","unstructured":"Newborn screening: toward a uniform screening panel and system[J]. Genet Med (2006) 8 Suppl 1(Suppl 1): 1s-252s. https:\/\/doi.org\/10.1097\/01.gim.0000223891.82390.ad","DOI":"10.1097\/01.gim.0000223891.82390.ad"},{"issue":"7","key":"9184_CR38","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.2014.9132","volume":"312","author":"A Kwan","year":"2014","unstructured":"Kwan A, Abraham RS, Currier R et al (2014) Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States[J]. JAMA 312(7):729\u2013738. https:\/\/doi.org\/10.1001\/jama.2014.9132","journal-title":"JAMA"},{"issue":"1","key":"9184_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12016-021-08876-z","volume":"63","author":"LJ Kobrynski","year":"2022","unstructured":"Kobrynski LJ (2022) Newborn Screening in the Diagnosis of Primary Immunodeficiency[J]. Clin Rev Allergy Immunol 63(1):9\u201321. https:\/\/doi.org\/10.1007\/s12016-021-08876-z","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"9184_CR40","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jaci.2011.03.040","volume":"127","author":"C Azzari","year":"2011","unstructured":"Azzari C, la Marca G, Resti M (2011) Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry[J]. J Allergy Clin Immunol 127(6):1394\u20131399. https:\/\/doi.org\/10.1016\/j.jaci.2011.03.040","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"9184_CR41","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1182\/blood-2011-08-371021","volume":"119","author":"S Borte","year":"2012","unstructured":"Borte S, von D\u00f6beln U, Fasth A et al (2012) Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR[J]. Blood 119(11):2552\u20132555. https:\/\/doi.org\/10.1182\/blood-2011-08-371021","journal-title":"Blood"},{"issue":"3","key":"9184_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10875-014-0007-6","volume":"34","author":"SP Adams","year":"2014","unstructured":"Adams SP, Rashid S, Premachandra T et al (2014) Screening of neonatal UK dried blood spots using a duplex TREC screening assay[J]. J Clin Immunol 34(3):323\u2013330. https:\/\/doi.org\/10.1007\/s10875-014-0007-6","journal-title":"J Clin Immunol"},{"issue":"2","key":"9184_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.clim.2013.11.012","volume":"150","author":"M Audrain","year":"2014","unstructured":"Audrain M, Thomas C, Mirallie S et al (2014) Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study[J]. Clin Immunol 150(2):137\u2013139. https:\/\/doi.org\/10.1016\/j.clim.2013.11.012","journal-title":"Clin Immunol"},{"issue":"1","key":"9184_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/pai.12501","volume":"27","author":"B de Felipe","year":"2016","unstructured":"de Felipe B, Olbrich P, Lucenas JM et al (2016) Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville[J]. Pediatr Allergy Immunol 27(1):70\u201377. https:\/\/doi.org\/10.1111\/pai.12501","journal-title":"Pediatr Allergy Immunol"},{"key":"9184_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clim.2017.05.007","volume":"180","author":"M Blom","year":"2017","unstructured":"Blom M, Pico-Knijnenburg I, Sijne-van Veen M et al (2017) An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program[J]. Clin Immunol 180:106\u2013110. https:\/\/doi.org\/10.1016\/j.clim.2017.05.007","journal-title":"Clin Immunol"},{"issue":"1","key":"9184_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10875-016-0347-5","volume":"37","author":"M Barbaro","year":"2017","unstructured":"Barbaro M, Ohlsson A, Borte S et al (2017) Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study[J]. J Clin Immunol 37(1):51\u201360. https:\/\/doi.org\/10.1007\/s10875-016-0347-5","journal-title":"J Clin Immunol"},{"key":"9184_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clim.2016.11.016","volume":"175","author":"L Tagliaferri","year":"2017","unstructured":"Tagliaferri L, Kunz JB, Happich M et al (2017) Newborn screening for severe combined immunodeficiency using a novel and simplified method to measure T-cell excision circles (TREC)[J]. Clin Immunol 175:51\u201355. https:\/\/doi.org\/10.1016\/j.clim.2016.11.016","journal-title":"Clin Immunol"},{"issue":"2","key":"9184_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaci.2024.10.018","volume":"155","author":"M Blom","year":"2025","unstructured":"Blom M, Soomann M, Soler-Palac\u00edn P et al (2025) Newborn screening for SCID and severe T lymphocytopenia in Europe[J]. J Allergy Clin Immunol 155(2):377\u2013386. https:\/\/doi.org\/10.1016\/j.jaci.2024.10.018","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9184_CR49","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10875-023-01450-6","volume":"43","author":"C Speckmann","year":"2023","unstructured":"Speckmann C, Nennstiel U, H\u00f6nig M et al (2023) Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)[J]. J Clin Immunol 43(5):965\u2013978. https:\/\/doi.org\/10.1007\/s10875-023-01450-6","journal-title":"J Clin Immunol"},{"key":"9184_CR50","doi-asserted-by":"publisher","unstructured":"Heather N, de Hora M, Brothers S et al (2022) Introducing newborn screening for severe combined immunodeficiency-The New Zealand experience[J]. Int J Neonatal Screen 8(2). https:\/\/doi.org\/10.3390\/ijns8020033","DOI":"10.3390\/ijns8020033"},{"key":"9184_CR51","doi-asserted-by":"publisher","unstructured":"Shih STF, Keller E, Wiley V et al (2022) Economic evaluation of newborn screening for severe combined immunodeficiency[J]. Int J Neonatal Screen 8(3). https:\/\/doi.org\/10.3390\/ijns8030044","DOI":"10.3390\/ijns8030044"},{"issue":"1","key":"9184_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2011.01.052","volume":"128","author":"N Nakagawa","year":"2011","unstructured":"Nakagawa N, Imai K, Kanegane H et al (2011) Quantification of \u03ba-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects[J]. J Allergy Clin Immunol 128(1):223. https:\/\/doi.org\/10.1016\/j.jaci.2011.01.052. 5.e2","journal-title":"J Allergy Clin Immunol"},{"key":"9184_CR53","doi-asserted-by":"publisher","unstructured":"Graafen L, Speckmann C, Bakhtiar S et al (2026) Syndromic inborn errors of immunity in TREC-Newborn Screening: 5-year experience from the German screening program[J]. J Clin Immunol 46(1). https:\/\/doi.org\/10.1007\/s10875-026-01995-2","DOI":"10.1007\/s10875-026-01995-2"},{"issue":"5","key":"9184_CR54","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jaip.2026.02.032","volume":"14","author":"J Aluri","year":"2026","unstructured":"Aluri J, Gaviglio A, Kistler I et al (2026) Assessment of TREC-Based NBS SCID Reporting Practices for Harmonization of Results and Interpretation: A Global Survey[J]. J Allergy Clin Immunol Pract 14(5):1153\u20131164. https:\/\/doi.org\/10.1016\/j.jaip.2026.02.032","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"9184_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jfma.2012.10.020","volume":"114","author":"YH Chien","year":"2015","unstructured":"Chien YH, Chiang SC, Chang KL et al (2015) Incidence of severe combined immunodeficiency through newborn screening in a Chinese population[J]. J Formos Med Assoc 114(1):12\u201316. https:\/\/doi.org\/10.1016\/j.jfma.2012.10.020","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"9184_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijns3030016","volume":"3","author":"Y-H Chien","year":"2017","unstructured":"Chien Y-H, Yu H-H, Lee N-C et al (2017) Newborn Screening for Severe Combined Immunodeficiency in Taiwan[J]. Int J Neonatal Screen 3(3):16","journal-title":"Int J Neonatal Screen"},{"issue":"12","key":"9184_CR57","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s12519-024-00846-7","volume":"20","author":"C Chen","year":"2024","unstructured":"Chen C, Zhang C, Wu DW et al (2024) Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience[J]. World J Pediatr 20(12):1270\u20131282. https:\/\/doi.org\/10.1007\/s12519-024-00846-7","journal-title":"World J Pediatr"},{"key":"9184_CR58","doi-asserted-by":"publisher","first-page":"112402","DOI":"10.1016\/j.intimp.2024.112402","volume":"137","author":"X Yang","year":"2024","unstructured":"Yang X, He J, Peng W et al (2024) Opening SCID newborn screening for novel exon genetic variants through whole-exome sequencing in China[J]. Int Immunopharmacol 137:112402. https:\/\/doi.org\/10.1016\/j.intimp.2024.112402","journal-title":"Int Immunopharmacol"},{"issue":"04","key":"9184_CR59","first-page":"245","volume":"39","author":"China Healthy Birth Science Association MaCHMB","year":"2024","unstructured":"China Healthy Birth Science Association MaCHMB (2024) Expert consensus on diagnosis, immune reconstruction, and reproduction for infants with positive newborn screening of severe combined immunodeficiency[J]. Chin J Appl Clin Pediatr 39(04):245\u2013253 (Chinese)","journal-title":"Chin J Appl Clin Pediatr"},{"key":"9184_CR60","doi-asserted-by":"publisher","unstructured":"Bonilla FA, Khan DA, Ballas ZK et al (2015) Practice parameter for the diagnosis and management of primary immunodeficiency[J]. J Allergy Clin Immunol 136(5): 1186-205.e1-78. https:\/\/doi.org\/10.1016\/j.jaci.2015.04.049","DOI":"10.1016\/j.jaci.2015.04.049"},{"issue":"3","key":"9184_CR61","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jaci.2017.01.005","volume":"139","author":"MJ Dorsey","year":"2017","unstructured":"Dorsey MJ, Dvorak CC, Cowan MJ et al (2017) Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening[J]. J Allergy Clin Immunol 139(3):733\u2013742. https:\/\/doi.org\/10.1016\/j.jaci.2017.01.005","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"9184_CR62","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/archdischild-2014-306425","volume":"100","author":"L Rivers","year":"2015","unstructured":"Rivers L, Gaspar HB (2015) Severe combined immunodeficiency: recent developments and guidance on clinical management[J]. Arch Dis Child 100(7):667\u2013672. https:\/\/doi.org\/10.1136\/archdischild-2014-306425","journal-title":"Arch Dis Child"},{"issue":"8205","key":"9184_CR63","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/s0140-6736(80)92594-5","volume":"2","author":"HD Ochs","year":"1980","unstructured":"Ochs HD, Buckley RH, Pirofsky B et al (1980) Safety and patient acceptability of intravenous immune globulin in 10% maltose[J]. Lancet 2(8205):1158\u20131159. https:\/\/doi.org\/10.1016\/s0140-6736(80)92594-5","journal-title":"Lancet"},{"key":"9184_CR64","first-page":"24","volume":"16","author":"L Shi","year":"2021","unstructured":"Shi L, Zhang F, Sun Z et al (2021) Investigation on diagnosis, treatment and medical insurance of children with primary immunodeficiency diseases in China[J]. China J Pharm Econ 16:24\u201329","journal-title":"China J Pharm Econ"},{"issue":"1","key":"9184_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/1744666x.2023.2144836","volume":"19","author":"S Gupta","year":"2023","unstructured":"Gupta S, Kobayashi RH, Litzman J et al (2023) Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency[J]. Expert Rev Clin Immunol 19(1):7\u201317. https:\/\/doi.org\/10.1080\/1744666x.2023.2144836","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"9184_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12016-022-08950-0","volume":"65","author":"K Paris","year":"2023","unstructured":"Paris K, Wall LA (2023) The Treatment of Primary Immune Deficiencies: Lessons Learned and Future Opportunities[J]. Clin Rev Allergy Immunol 65(1):19\u201330. https:\/\/doi.org\/10.1007\/s12016-022-08950-0","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"9184_CR67","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10875-025-01952-5","volume":"45","author":"WR Lumry","year":"2025","unstructured":"Lumry WR, Palumbo M, Hsu C et al (2025) A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly\/Biweekly Dosing in Treatment-Experienced Patients and Loading\/Weekly Maintenance Dosing in Treatment-Na\u00efve Patients with Primary Immunodeficiency[J]. J Clin Immunol 45(1):158. https:\/\/doi.org\/10.1007\/s10875-025-01952-5","journal-title":"J Clin Immunol"},{"issue":"10","key":"9184_CR68","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1016\/j.jaip.2025.05.059","volume":"13","author":"NC Patel","year":"2025","unstructured":"Patel NC, Walter JE (2025) Facilitated Subcutaneous Immunoglobulin 10% Safety Among Pediatric Patients With Primary Immunodeficiency Diseases[J]. J Allergy Clin Immunol Pract 13(10):2590\u20132599. https:\/\/doi.org\/10.1016\/j.jaip.2025.05.059","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9184_CR69","doi-asserted-by":"publisher","first-page":"984110","DOI":"10.3389\/fimmu.2022.984110","volume":"13","author":"AKC Kan","year":"2022","unstructured":"Kan AKC, Leung GMK, Chiang V et al (2022) Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese[J]. Front Immunol 13:984110. https:\/\/doi.org\/10.3389\/fimmu.2022.984110","journal-title":"Front Immunol"},{"issue":"6","key":"9184_CR70","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jaci.2024.07.031","volume":"154","author":"AY Kreins","year":"2024","unstructured":"Kreins AY, Dhalla F, Flinn AM et al (2024) European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia[J]. J Allergy Clin Immunol 154(6):1391\u20131408. https:\/\/doi.org\/10.1016\/j.jaci.2024.07.031","journal-title":"J Allergy Clin Immunol"},{"key":"9184_CR71","doi-asserted-by":"publisher","unstructured":"Mitchell R (2019) Hematopoietic stem cell transplantation beyond severe combined immunodeficiency: Seeking a cure for primary immunodeficiency[J]. J Allergy Clin Immunol Pract 7(3): 776\u2009\u2013\u200985. https:\/\/doi.org\/10.1016\/j.jaip.2018.12.011","DOI":"10.1016\/j.jaip.2018.12.011"},{"key":"9184_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.05.020","author":"DE Arnold","year":"2025","unstructured":"Arnold DE, Leiding JW, Logan B et al (2025) Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report[J]. Transpl Cell Ther. https:\/\/doi.org\/10.1016\/j.jtct.2025.05.020","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"9184_CR73","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41409-025-02538-w","volume":"60","author":"AHG Stuut","year":"2025","unstructured":"Stuut AHG, Nijssen C, van der Wagen L et al (2025) Improved GVHD-free and relapse-free survival after ex vivo \u03b1\u03b2TCR and CD19 depleted allogeneic HSCT compared to T cell replete HSCT[J]. Bone Marrow Transpl 60(5):673\u2013681. https:\/\/doi.org\/10.1038\/s41409-025-02538-w","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"9184_CR74","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","volume":"141","author":"RM Shah","year":"2018","unstructured":"Shah RM, Elfeky R, Nademi Z et al (2018) T-cell receptor \u03b1\u03b2(+) and CD19(+) cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency[J]. J Allergy Clin Immunol 141(4):1417\u201326e1. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.008","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9184_CR75","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1182\/blood.2024024038","volume":"144","author":"SH Lum","year":"2024","unstructured":"Lum SH, Albert MH, Gilbert P et al (2024) Outcomes of HLA-mismatched HSCT with TCR\u03b1\u03b2\/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity[J]. Blood 144(5):565\u2013580. https:\/\/doi.org\/10.1182\/blood.2024024038","journal-title":"Blood"},{"issue":"12","key":"9184_CR76","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41409-024-02419-8","volume":"59","author":"LP Xu","year":"2024","unstructured":"Xu LP, Lu PH, Wu DP et al (2024) Hematopoietic stem cell transplantation activity in China 2022\u20132023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group[J]. Bone Marrow Transpl 59(12):1726\u20131734. https:\/\/doi.org\/10.1038\/s41409-024-02419-8","journal-title":"Bone Marrow Transpl"},{"key":"9184_CR77","doi-asserted-by":"publisher","unstructured":"Zhang ZY, An YF, Jiang LP et al (2013) Distribution, clinical features and molecular analysis of primary immunodeficiency diseases in Chinese children: a single-center study from 2005 to 2011[J]. Pediatr Infect Dis J 32(10):1127\u20131134. https:\/\/doi.org\/10.1097\/INF.0b013e31829aa9e9","DOI":"10.1097\/INF.0b013e31829aa9e9"},{"issue":"10","key":"9184_CR78","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00431-015-2527-3","volume":"174","author":"N Chen","year":"2015","unstructured":"Chen N, Zhang ZY, Liu DW et al (2015) The clinical features of autoimmunity in 53 patients with Wiskott-Aldrich syndrome in China: a single-center study[J]. Eur J Pediatr 174(10):1311\u20131318. https:\/\/doi.org\/10.1007\/s00431-015-2527-3","journal-title":"Eur J Pediatr"},{"issue":"4","key":"9184_CR79","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10875-022-01218-4","volume":"42","author":"L Qiu","year":"2022","unstructured":"Qiu L, Wang Y, Tang W et al (2022) Activated Phosphoinositide 3-Kinase \u03b4 Syndrome: a Large Pediatric Cohort from a Single Center in China[J]. J Clin Immunol 42(4):837\u2013850. https:\/\/doi.org\/10.1007\/s10875-022-01218-4","journal-title":"J Clin Immunol"},{"issue":"6","key":"9184_CR80","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s10875-019-00672-x","volume":"39","author":"W Ying","year":"2019","unstructured":"Ying W, Liu D, Dong X et al (2019) Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China[J]. J Clin Immunol 39(6):600\u2013610. https:\/\/doi.org\/10.1007\/s10875-019-00672-x","journal-title":"J Clin Immunol"},{"issue":"9915","key":"9184_CR81","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/s0140-6736(13)62069-3","volume":"383","author":"T G\u00fcng\u00f6r","year":"2014","unstructured":"G\u00fcng\u00f6r T, Teira P, Slatter M et al (2014) Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study[J]. Lancet 383(9915):436\u2013448. https:\/\/doi.org\/10.1016\/s0140-6736(13)62069-3","journal-title":"Lancet"},{"issue":"9","key":"9184_CR82","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","volume":"56","author":"AC Lankester","year":"2021","unstructured":"Lankester AC, Albert MH, Booth C et al (2021) EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity[J]. Bone Marrow Transpl 56(9):2052\u20132062. https:\/\/doi.org\/10.1038\/s41409-021-01378-8","journal-title":"Bone Marrow Transpl"},{"issue":"25","key":"9184_CR83","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","volume":"130","author":"J Heimall","year":"2017","unstructured":"Heimall J, Logan BR, Cowan MJ et al (2017) Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study[J]. Blood 130(25):2718\u20132727. https:\/\/doi.org\/10.1182\/blood-2017-05-781849","journal-title":"Blood"},{"issue":"14","key":"9184_CR84","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1182\/blood.2022015506","volume":"140","author":"MH Albert","year":"2022","unstructured":"Albert MH, Sirait T, Eikema DJ et al (2022) Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study[J]. Blood 140(14):1635\u20131649. https:\/\/doi.org\/10.1182\/blood.2022015506","journal-title":"Blood"},{"key":"9184_CR85","doi-asserted-by":"publisher","first-page":"109919","DOI":"10.1016\/j.clim.2024.109919","volume":"260","author":"Y Si","year":"2024","unstructured":"Si Y, Dou Y, Zhai X et al (2024) Effect of allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease in children: A multicentre, retrospective cohort study in China[J]. Clin Immunol 260:109919. https:\/\/doi.org\/10.1016\/j.clim.2024.109919","journal-title":"Clin Immunol"},{"issue":"9","key":"9184_CR86","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1007\/s00277-025-06600-x","volume":"104","author":"S Hu","year":"2025","unstructured":"Hu S, Wang P, Li Z et al (2025) A cohort of allogeneic hematopoietic stem cell transplantation for pediatric rare diseases (allo-HSCT-PRD): design and preliminary results[J]. Ann Hematol 104(9):4821\u20134830. https:\/\/doi.org\/10.1007\/s00277-025-06600-x","journal-title":"Ann Hematol"},{"key":"9184_CR87","doi-asserted-by":"publisher","unstructured":"Seidel MG, Hauck F (2024) Multilayer concept of autoimmune mechanisms and manifestations in inborn errors of immunity: Relevance for precision therapy[J]. J Allergy Clin Immunol 153(3): 615\u2009\u2013\u200928.e4. https:\/\/doi.org\/10.1016\/j.jaci.2023.12.022","DOI":"10.1016\/j.jaci.2023.12.022"},{"issue":"1","key":"9184_CR88","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaci.2015.08.036","volume":"137","author":"S Lee","year":"2016","unstructured":"Lee S, Moon JS, Lee CR et al (2016) Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4[J]. J Allergy Clin Immunol 137(1):327\u2013330. https:\/\/doi.org\/10.1016\/j.jaci.2015.08.036","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"9184_CR89","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","volume":"142","author":"C Schwab","year":"2018","unstructured":"Schwab C, Gabrysch A, Olbrich P et al (2018) Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects[J]. J Allergy Clin Immunol 142(6):1932\u20131946. https:\/\/doi.org\/10.1016\/j.jaci.2018.02.055","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"9184_CR90","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jaci.2023.08.004","volume":"152","author":"N Taghizade","year":"2023","unstructured":"Taghizade N, Babayeva R, Kara A et al (2023) Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency[J]. J Allergy Clin Immunol 152(6):1634\u20131645. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.004","journal-title":"J Allergy Clin Immunol"},{"key":"9184_CR91","doi-asserted-by":"publisher","first-page":"717388","DOI":"10.3389\/fimmu.2021.717388","volume":"12","author":"J Hadjadj","year":"2021","unstructured":"Hadjadj J, Fr\u00e9mond ML, Neven B (2021) Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity[J]. Front Immunol 12:717388. https:\/\/doi.org\/10.3389\/fimmu.2021.717388","journal-title":"Front Immunol"},{"key":"9184_CR92","doi-asserted-by":"publisher","unstructured":"Fischer M, Olbrich P, Hadjadj J et al (2024) JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: An ESID\/EBMT-IEWP retrospective study[J]. J Allergy Clin Immunol 153(1) 275\u2009\u2013\u200986.e18. https:\/\/doi.org\/10.1016\/j.jaci.2023.10.018","DOI":"10.1016\/j.jaci.2023.10.018"},{"issue":"5","key":"9184_CR93","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/422993","volume":"39","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Wesley R, De Carlo ES et al (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease[J]. Clin Infect Dis 39(5):692\u2013699. https:\/\/doi.org\/10.1086\/422993","journal-title":"Clin Infect Dis"},{"issue":"20","key":"9184_CR94","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1182\/bloodadvances.2025016213","volume":"9","author":"M Bruno","year":"2025","unstructured":"Bruno M, Kr\u00f6ger C, Ferreira AV et al (2025) Interferon gamma rebalances immunopathological signatures in chronic granulomatous disease through metabolic rewiring[J]. Blood Adv 9(20):5306\u20135322. https:\/\/doi.org\/10.1182\/bloodadvances.2025016213","journal-title":"Blood Adv"},{"issue":"21","key":"9184_CR95","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","volume":"130","author":"VK Rao","year":"2017","unstructured":"Rao VK, Webster S, Dalm V et al (2017) Effective activated PI3K\u03b4 syndrome-targeted therapy with the PI3K\u03b4 inhibitor leniolisib[J]. Blood 130(21):2307\u20132316. https:\/\/doi.org\/10.1182\/blood-2017-08-801191","journal-title":"Blood"},{"key":"9184_CR96","doi-asserted-by":"publisher","first-page":"928213","DOI":"10.3389\/fimmu.2022.928213","volume":"13","author":"Y Xie","year":"2022","unstructured":"Xie Y, Shao F, Lei J et al (2022) Case report: A STAT1 gain-of-function mutation causes a syndrome of combined immunodeficiency, autoimmunity and pure red cell aplasia[J]. Front Immunol 13:928213. https:\/\/doi.org\/10.3389\/fimmu.2022.928213","journal-title":"Front Immunol"},{"issue":"1","key":"9184_CR97","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10875-025-01937-4","volume":"45","author":"Y Xiang","year":"2025","unstructured":"Xiang Y, Sun S, Wang H et al (2025) A Child with Chronic Mucocutaneous Candidiasis Harbors a Novel Gain-of-Function Mutation in STAT1[J]. J Clin Immunol 45(1):137. https:\/\/doi.org\/10.1007\/s10875-025-01937-4","journal-title":"J Clin Immunol"},{"key":"9184_CR98","doi-asserted-by":"publisher","first-page":"1622764","DOI":"10.3389\/fimmu.2025.1622764","volume":"16","author":"Z Huang","year":"2025","unstructured":"Huang Z, Wang Y, Wei R et al (2025) Activated PI3K-\u03b4 syndrome presenting with cervical lymphadenopathy in a pediatric patient: a case report and review of the literature[J]. Front Immunol 16:1622764. https:\/\/doi.org\/10.3389\/fimmu.2025.1622764","journal-title":"Front Immunol"},{"issue":"1","key":"9184_CR99","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13223-023-00840-0","volume":"19","author":"L Jiang","year":"2023","unstructured":"Jiang L, Hu X, Lin Q et al (2023) Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase \u03b4 syndrome 1[J]. Allergy Asthma Clin Immunol 19(1):86. https:\/\/doi.org\/10.1186\/s13223-023-00840-0","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"10\u201312","key":"9184_CR100","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00011-021-01479-6","volume":"70","author":"G Su","year":"2021","unstructured":"Su G, Lai J, Zhu J et al (2021) Analysis of five cases of monogenic lupus related to primary immunodeficiency diseases[J]. Inflamm Res 70(10\u201312):1211\u20131216. https:\/\/doi.org\/10.1007\/s00011-021-01479-6","journal-title":"Inflamm Res"},{"issue":"5","key":"9184_CR101","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.gendis.2020.03.001","volume":"8","author":"L Yang","year":"2021","unstructured":"Yang L, Xue X, Chen X et al (2021) Abatacept is effective in Chinese patients with LRBA and CTLA4 deficiency[J]. Genes Dis 8(5):662\u2013668. https:\/\/doi.org\/10.1016\/j.gendis.2020.03.001","journal-title":"Genes Dis"},{"key":"9184_CR102","doi-asserted-by":"publisher","first-page":"8745254","DOI":"10.1155\/2017\/8745254","volume":"2017","author":"J Wu","year":"2017","unstructured":"Wu J, Wang WF, Zhang YD et al (2017) Clinical Features and Genetic Analysis of 48 Patients with Chronic Granulomatous Disease in a Single Center Study from Shanghai, China (2005\u20132015): New Studies and a Literature Review[J]. J Immunol Res 2017:8745254. https:\/\/doi.org\/10.1155\/2017\/8745254","journal-title":"J Immunol Res"},{"issue":"12","key":"9184_CR103","doi-asserted-by":"publisher","first-page":"e22632","DOI":"10.1016\/j.heliyon.2023.e22632","volume":"9","author":"Y Yang","year":"2023","unstructured":"Yang Y, Xia L, Lu S (2023) Adult-onset Mendelian Susceptibility to Mycobacterial Diseases: A case report and systematic literature review[J]. Heliyon 9(12):e22632. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22632","journal-title":"Heliyon"},{"issue":"3","key":"9184_CR104","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jaip.2018.12.017","volume":"7","author":"JW Leiding","year":"2019","unstructured":"Leiding JW, Forbes LR (2019) Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases[J]. J Allergy Clin Immunol Pract 7(3):761\u2013773. https:\/\/doi.org\/10.1016\/j.jaip.2018.12.017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"9184_CR105","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1172\/jci35798","volume":"118","author":"SJ Howe","year":"2008","unstructured":"Howe SJ, Mansour MR, Schwarzwaelder K et al (2008) Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients[J]. J Clin Invest 118(9):3143\u20133150. https:\/\/doi.org\/10.1172\/jci35798","journal-title":"J Clin Invest"},{"issue":"6","key":"9184_CR106","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15252\/emmm.201707573","volume":"9","author":"A Aiuti","year":"2017","unstructured":"Aiuti A, Roncarolo MG, Naldini L (2017) Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products[J]. EMBO Mol Med 9(6):737\u2013740. https:\/\/doi.org\/10.15252\/emmm.201707573","journal-title":"EMBO Mol Med"},{"issue":"21","key":"9184_CR107","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","volume":"384","author":"DB Kohn","year":"2021","unstructured":"Kohn DB, Booth C, Shaw KL et al (2021) Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency[J]. N Engl J Med 384(21):2002\u20132013. https:\/\/doi.org\/10.1056\/NEJMoa2027675","journal-title":"N Engl J Med"},{"issue":"16","key":"9184_CR108","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","volume":"380","author":"E Mamcarz","year":"2019","unstructured":"Mamcarz E, Zhou S, Lockey T et al (2019) Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1[J]. N Engl J Med 380(16):1525\u20131534. https:\/\/doi.org\/10.1056\/NEJMoa1815408","journal-title":"N Engl J Med"},{"issue":"2","key":"9184_CR109","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","volume":"26","author":"DB Kohn","year":"2020","unstructured":"Kohn DB, Booth C, Kang EM et al (2020) Lentiviral gene therapy for X-linked chronic granulomatous disease[J]. Nat Med 26(2):200\u2013206. https:\/\/doi.org\/10.1038\/s41591-019-0735-5","journal-title":"Nat Med"},{"issue":"25","key":"9184_CR110","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1056\/NEJMoa2206575","volume":"387","author":"MJ Cowan","year":"2022","unstructured":"Cowan MJ, Yu J, Facchino J et al (2022) Lentiviral Gene Therapy for Artemis-Deficient SCID[J]. N Engl J Med 387(25):2344\u20132355. https:\/\/doi.org\/10.1056\/NEJMoa2206575","journal-title":"N Engl J Med"},{"issue":"1","key":"9184_CR111","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1182\/hematology.2019000052","volume":"2019","author":"SY Pai","year":"2019","unstructured":"Pai SY (2019) Treatment of primary immunodeficiency with allogeneic transplant and gene therapy[J]. Hematol Am Soc Hematol Educ Program 2019(1):457\u2013465. https:\/\/doi.org\/10.1182\/hematology.2019000052","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"9184_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.10.033","author":"DJA Bogaert","year":"2025","unstructured":"Bogaert DJA, Wolfsberger CH, Attarbaschi A et al (2025) Epidemiology and management of malignancies in patients with inborn errors of immunity-An ESID registry study of 19,959 patients[J]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2025.10.033","journal-title":"J Allergy Clin Immunol"},{"key":"9184_CR113","doi-asserted-by":"publisher","first-page":"1371124","DOI":"10.3389\/fimmu.2024.1371124","volume":"15","author":"N Xiao","year":"2024","unstructured":"Xiao N, Huang X, Zang W et al (2024) Health-related quality of life in patients with inborn errors of immunity: a bibliometric analysis[J]. Front Immunol 15:1371124. https:\/\/doi.org\/10.3389\/fimmu.2024.1371124","journal-title":"Front Immunol"},{"issue":"1","key":"9184_CR114","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10875-025-01904-z","volume":"45","author":"M Blom","year":"2025","unstructured":"Blom M, Duintjer AJ, Jamee M et al (2025) Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis[J]. J Clin Immunol 45(1):125. https:\/\/doi.org\/10.1007\/s10875-025-01904-z","journal-title":"J Clin Immunol"},{"issue":"6","key":"9184_CR115","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jaci.2025.08.015","volume":"156","author":"C Murray","year":"2025","unstructured":"Murray C, Santangeli E, Mockler D et al (2025) A scoping review of clinical management guidelines in inborn errors of immunity[J]. J Allergy Clin Immunol 156(6):1715\u20131724. https:\/\/doi.org\/10.1016\/j.jaci.2025.08.015","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-026-09184-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:26:40Z","timestamp":1785518800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-026-09184-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9184"],"URL":"https:\/\/doi.org\/10.1007\/s12016-026-09184-0","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"60"}}